Trial halted: testing combo therapy for Tough-to-Treat uterine cancers
NCT ID NCT05481645
Summary
This study tested a new treatment combination for people with advanced endometrial cancer or uterine sarcoma who had not yet received other treatments. It combined an immunotherapy drug (TQB2450) and chemotherapy, with or without a targeted therapy pill (anlotinib). The goal was to see if this combination could shrink tumors and control the disease, followed by a maintenance phase to try to keep the cancer from growing back. The trial was terminated early and enrolled 71 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, 110801, China
-
Linyi Cancer Hospital
Linyi, Shandong, 276002, China
-
Obstetrics & Gynecology Hospital of Fudan University
Shanghai, Shanghai Municipality, 200090, China
-
Shandong Cancer Hospital
Jinan, Shandong, 250117, China
-
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, 510120, China
-
Taizhou People's Hospital
Taizhou, Jiangsu, 225399, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710061, China
-
TianJin Medical University Cancer Institute & Hopspital
Tianjin, Tianjin Municipality, 300181, China
-
Yantai Yuhuangding Hospital
Yantai, Shandong, 264099, China
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430062, China
Conditions
Explore the condition pages connected to this study.